Work

The Aurora Kinase Inhibitor MLN8237 Has Potent Anticancer Activity in CML and Ph+ ALL Models and Significantly Increases the Efficacy of Nilotinib

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.3198.3198

Authors: Steffan T. Nawrocki, Ernest Medina, Sabrina Smith, Ronan Swords, Kevin Kelly, Swaminathan Padmanabhan, Jeffrey Ecsedy, Francis J Giles, Jennifer Carew

Institutions: The University of Texas at San Antonio Health Science Center, Takeda Oncology (United States)

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2562652923

FWCI: 1.145

Cites:

Cited by: 6

Related to: 10